These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29529549)

  • 1. Corrigendum to "Change in 1-year hospitalization of overall and older patients with major depressive disorder after second-generation antipsychotics augmentation treatment" [J. Affect. Disord. 230(1) (2018) 118-124].
    Lin CY; Lai TJ; Wu YH; Chen PK; Lin YF; Chien IC
    J Affect Disord; 2018 Jul; 234():162-163. PubMed ID: 29529549
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up - Results from the Finnish Health 2011 Survey" [J. Affect. Disord. 173 (2015) 73-80].
    Markkula N; Suvisaari J; Saarni SI; Pirkola S; Peña S; Saarni S; Ahola K; Mattila AK; Viertiö S; Strehle J; Koskinen S; Härkänen T
    J Affect Disord; 2017 Feb; 209():16-17. PubMed ID: 27866045
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1].
    Mischoulon D; Hylek L; Yeung AS; Clain AJ; Baer L; Cusin C; Ionescu DF; Alpert JE; Soskin DP; Fava M
    J Affect Disord; 2018 Feb; 227():198. PubMed ID: 29100152
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Association of obesity with cognitive function and brain structure in patients with major depressive disorder" [J. Affect. Disord. 225 (2018) 188-194].
    Hidese S; Ota M; Matsuo J; Ishida I; Hiraishi M; Yoshida S; Noda T; Sato N; Teraishi T; Hattori K; Kunugi H
    J Affect Disord; 2018 Aug; 236():314. PubMed ID: 29046217
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population" [J. Affect. Disord. 185 (2015) 149-155].
    Chen J; Wang M; Khan RAW; He K; Wang Q; Li Z; Shen J; Song Z; Li W; Wen Z; Jiang Y; Xu Y; Shi Y; Ji W
    J Affect Disord; 2017 Oct; 221():267. PubMed ID: 28662458
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan" [J. Affect. Disord. 189 (2016) 110-117].
    Lee MJ; Yang KC; Shyu YC; Yuan SS; Yang CJ; Lee SY; Lee TL; Wang LJ
    J Affect Disord; 2016 Jan; 190():122. PubMed ID: 28835009
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Physical activity and sedentary behavior in people with major depressive disorder: A systematic review and meta-analysis" [J. Affect. Disord. 210 (2017) 139-150].
    Schuch F; Vancampfort D; Firth J; Rosenbaum S; Ward P; Reichert T; Carvalho Bagatini N; Bgeginski R; Stubbs B
    J Affect Disord; 2018 Jan; 225():79. PubMed ID: 28802116
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Abnormal brain gray matter volume in patients with major depressive disorder: Associated with childhood trauma?" [J. Affect. Disord. Volume 308, 1 July 2022, 562-568].
    Liu Y; Zhang J; Zhang M; Li X; Li K; Wang B; Yang Y; Song R; Si Y; Ni T; Wang X; Geng Y; Chang Q; Zhang H; Zhang Z; Zhang H
    J Affect Disord; 2022 Aug; 310():493. PubMed ID: 35597616
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to: "Prevalence of major depressive disorder and socio-demographic correlates: Results of a representative household epidemiological survey in Beijing, China" [J. Affect. Disord. 179 (2015) 74-81].
    Liu J; Yan F; Ma X; Guo HL; Tang YL; Rakofsky JJ; Wu XM; Li XQ; Zhu H; Guo XB; Yang Y; Li P; Cao XD; Li HY; Li ZB; Wang P; Xu QY
    J Affect Disord; 2016 Jun; 197():8. PubMed ID: 27090235
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to: Antidepressants worsen rapid-cycling course in bipolar disorder: A STEP-BD randomized clinical trial. J. Affect. Disord. (Jun. 10, 2015); http://dx.doi.org/10.1016/j.jad.2015.04.054.
    El-Mallakh RS; Vohringer PA; Ostacher MM; Baldassano CF; Holtzman NS; Whitham EA; Thommi SB; Goodwin FK; Ghaemi SN
    J Affect Disord; 2016 Jan; 190():895. PubMed ID: 28835013
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of augmentation agents for treating depression: analysis of a psychiatric electronic medical record data set.
    Gersing KR; Sheehan JJ; Burchett B; Zhu L; Bates JA; Baker RA; Kalsekar ID
    Psychiatr Serv; 2014 Aug; 65(8):1062-5. PubMed ID: 24932958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to "Music therapy as an adjunct to standard treatment for obsessive compulsive disorder and co-morbid anxiety and depression: A randomized clinical trial" [J. Affect. Disord. 184 (2015) 13-17].
    Shiranibidabadi S; Mehryar A
    J Affect Disord; 2017 Nov; 222():40. PubMed ID: 28668714
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Decreased plasma adiponectin among male firefighters with symptoms of post-traumatic stress disorder" [J. Affect. Disord. 221 (2017) 254-258].
    Na KS; Kim E; Park JT
    J Affect Disord; 2018 Jan; 225():657. PubMed ID: 28892794
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Network analysis of anxiety and depressive symptoms among nursing students during the COVID-19 pandemic" [J. Affect. Disord. 294 (2021): 753-760].
    Bai W; Xi HT; Zhu Q; Ji M; Zhang H; Yang BX; Cai H; Liu R; Zhao YJ; Chen L; Ge ZM; Wang Z; Han L; Chen P; Liu S; Cheung T; Tang YL; Jackson T; An F; Xiang YT
    J Affect Disord; 2023 May; 328():355. PubMed ID: 36774316
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Temperaments in psychotic and major affective disorders" [J. Affect. Disord. (2018) 195-200].
    Pompili M; Baldessarini RJ; Innamorati M; Vázquez GH; Rihmer Z; Gonda X; Forte A; Lamis DA; Erbuto D; Serafini G; Fiorillo A; Amore M; Girardi P
    J Affect Disord; 2018 Aug; 236():315. PubMed ID: 29102381
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations Between Medication Class and Subsequent Augmentation of Depression Treatment in Privately Insured US Adults.
    Ameli O; Soria-Saucedo R; Smith EG; Cabral HJ; Soley-Bori M; Kazis LE
    J Clin Psychopharmacol; 2017 Jun; 37(3):323-331. PubMed ID: 28338544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator." [J Affect Disord. 2018;233:92-99].
    Machado-Vieira R
    J Affect Disord; 2019 Jun; 253():. PubMed ID: 30180982
    [No Abstract]   [Full Text] [Related]  

  • 19. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.